Shara Nawar M, Resnick Helaine E, Lu Li, Xu Jiaqiong, Vupputuri Suma, Howard Barbara V, Umans Jason G
Department of Biostatistics, Epidemiology, Outcomes, and Data Management, MedStar Research Institute, Hyattsville, Maryland, USA.
J Nephrol. 2009 May-Jun;22(3):373-80.
Kidney function, expressed as glomerular filtration rate (GFR), is commonly estimated from serum creatinine (Scr) and, when decreased, may serve as a nonclassical risk factor for incident cardiovascular disease (CVD). The ability of estimated GFR (eGFR) to predict CVD events during 5-10 years of follow-up is assessed using data from the Strong Heart Study (SHS), a large cohort with a high prevalence of diabetes.
eGFRs were calculated with the abbreviated Modification of Diet in Renal Disease study (MDRD) and the Cockcroft-Gault (CG) equations. These estimates were compared in participants with normal and abnormal Scr. The association between eGFR and incident CVD was assessed.
More subjects were labeled as having low eGFR (<60 ml/min per 1.73 m2) by the MDRD or CG equation, than by Scr alone. When Scr was in the normal range, both equations labeled similar numbers of participants as having low eGFRs, although concordance between the equations was poor. However, when Scr was elevated, the MDRD equation labeled more subjects as having low eGFR. Persons with low eGFR had increased risk of CVD.
The MDRD and CG equations labeled more participants as having decreased GFR than did Scr alone. Decreased eGFR was predictive of CVD in this American Indian population with a high prevalence of obesity and type 2 diabetes mellitus.
以肾小球滤过率(GFR)表示的肾功能通常通过血清肌酐(Scr)来估算,当肾功能下降时,它可能作为新发心血管疾病(CVD)的非经典危险因素。利用来自强心脏研究(SHS)的数据评估估算肾小球滤过率(eGFR)在5至10年随访期间预测CVD事件的能力,SHS是一个糖尿病患病率很高的大型队列。
采用简化的肾脏疾病饮食改良研究(MDRD)方程和考克饶夫-高尔特(CG)方程计算eGFR。在Scr正常和异常的参与者中对这些估算值进行比较。评估eGFR与新发CVD之间的关联。
与仅根据Scr判断相比,更多受试者被MDRD或CG方程判定为eGFR较低(<60 ml/min per 1.73 m2)。当Scr处于正常范围时,两个方程判定为eGFR较低的参与者数量相似,尽管两个方程之间的一致性较差。然而,当Scr升高时,MDRD方程判定更多受试者eGFR较低。eGFR较低的人患CVD的风险增加。
与仅根据Scr判断相比,MDRD和CG方程判定更多参与者的GFR降低。在这个肥胖和2型糖尿病患病率很高的美国印第安人群中,eGFR降低可预测CVD。